Broader Implications of Eliminating FDA Jurisdiction Over Execution Drugs
- 1 October 2021
- journal article
- research article
- Published by American Public Health Association in American Journal of Public Health
- Vol. 111 (10), 1764-1767
- https://doi.org/10.2105/ajph.2021.306425
Abstract
No abstract availableKeywords
This publication has 2 references indexed in Scilit:
- Physician Participation in Lethal InjectionThe New England Journal of Medicine, 2019
- Regulating Compounding Pharmacies after NECCThe New England Journal of Medicine, 2012